All GLP-1 course drugs have boxed warnings about thyroid C-cell tumors observed in rodent scientific studies, while this risk has not been verified in human beings. The Pick out cardiovascular outcomes trial demonstrated that semaglutide actually decreased big adverse cardiovascular events by twenty%, giving reassurance about long-phrase cardiovasc